Introducing BiologicPatentWatch: Biotechnology Industry Competitive Intelligence

WASHINGTON - May 10, 2013 - PRLog -- After months of development, BiologicPatentWatch.com (http://www.biologicpatentwatch.com/) is live.

Building on the framework of DrugPatentWatch.com, BiologicPatentWatch.com provides comprehensive details on FDA approved biologic drugs, developers and patents. The integrated databases allow both freeform searching and dynamic browsing, making it easy to find information on drug patents both in the US and internationally, Orphan Drug Status, trends in patent expirations and more ...

BiologicPatentWatch.com concentrates deep knowledge on more than 100 biologic drugs from more than 60 biotechnology companies, including more than 2,800 active and expired US patents and 41,000 active and expired international patents spanning 91 countries and regional patent offices.

BiologicPatentWatch.com complements DrugPatentWatch.com's focus on small molecule drugs, and provides comprehensive information on:

monoclonal antibodies
cytokines, growth factors, enzymes, immunomodulators; and thrombolytics
proteins intended for therapeutic use that are extracted from animals or microorganisms, including recombinant versions of these products (except clotting factors)
other non-vaccine therapeutic immunotherapies

Check out the free biotechnology industry infographics (http://www.biologicpatentwatch.com/infographics/) and database preview (http://www.biologicpatentwatch.com/ultimate/), or sign up for a free trial (http://www.biologicpatentwatch.com/trial.php) today!